Novel Interactive Cell-phone tech for Health Enhancement

在美国，慢性病的负担是巨大的，70%的死亡可归因于某种形式的慢性病。由于大多数慢性病都是由可改变的行为引起的，并且严重程度各不相同，因此自我护理具有改善其病程的巨大潜力;然而，对自我护理计划的坚持往往很差。技术的进步可以使患者以新的方式坚持自我护理管理计划。Palaistra系统是一个突破性的无线远程患者监测和响应系统，它收集和传输患者数据，并通过蜂窝电话提供基于患者数据的每日交互式、个性化定制的信息消息。因此，促进采用和维持建议的生活方式改变和疾病监测/管理做法。因此，提出了一种新的交互式手机健康增强技术（NICHE），这是一项对照临床试验，旨在评估Palaistra系统在成人2型糖尿病管理中的可行性和有效性。这项I期STTR试验的可行性结果是在临床环境中成功实施，并验证了患者和临床医生满意度的测量结果。临床和疾病特异性结局包括：HbA 1c水平、BMI、体力活动水平、糖尿病自我护理知识和自我效能。

The burden of chronic disease in the United States is formidable, with 70% of all deaths attributable to some form of chronic illness. As the majority of chronic diseases arise from, and vary in severity with, modifiable behaviors, self-care has enormous potential to ameliorate their course; however, adherence to self-care plans is often poor. Advances in technology can empower patients in novel ways to adhere to self-care management plans. The Palaistra System is a breakthrough wireless remote patient monitoring and response system that collects and transmits patient data and provides daily interactive, individually tailored informative messages, based on patient data, via cellular phones. Adoption and maintenance of recommended lifestyle changes and disease monitoring/management practices are thus facilitated. Proposed, therefore, is Novel Interactive Cell-phone technology for Health Enhancement (NICHE), a controlled clinical trial evaluating the feasibility and efficacy of the Palaistra System in the management of type 2 diabetes in adults. Feasibility outcomes of this Phase I STTR trial are success of implementation in a clinical setting and validated measures of patient and clinician satisfaction. Clinical and disease-specific outcomes include: HbA1c levels, BMI, physical activity levels, diabetes self-care knowledge and self-efficacy.